• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体疗法的利弊。

Pros and cons of phage therapy.

作者信息

Loc-Carrillo Catherine, Abedon Stephen T

机构信息

Department of Orthopaedics; The University of Utah; Salt Lake City, UT USA.

出版信息

Bacteriophage. 2011 Mar;1(2):111-114. doi: 10.4161/bact.1.2.14590.

DOI:10.4161/bact.1.2.14590
PMID:22334867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3278648/
Abstract

Many publications list advantages and disadvantages associated with phage therapy, which is the use of bacterial viruses to combat populations of nuisance or pathogenic bacteria. The goal of this commentary is to discuss many of those issues in a single location. In terms of "Pros," for example, phages can be bactericidal, can increase in number over the course of treatment, tend to only minimally disrupt normal flora, are equally effective against antibiotic-sensitive and antibiotic-resistant bacteria, often are easily discovered, seem to be capable of disrupting bacterial biofilms, and can have low inherent toxicities. In addition to these assets, we consider aspects of phage therapy that can contribute to its safety, economics, or convenience, but in ways that are perhaps less essential to the phage potential to combat bacteria. For example, autonomous phage transfer between animals during veterinary application could provide convenience or economic advantages by decreasing the need for repeated phage application, but is not necessarily crucial to therapeutic success. We also consider possible disadvantages to phage use as antibacterial agents. These "Cons," however, tend to be relatively minor.

摘要

许多出版物都列出了与噬菌体疗法相关的优缺点,噬菌体疗法是利用细菌病毒来对抗有害或致病细菌群体。本评论的目的是在一个地方讨论其中的许多问题。例如,在“优点”方面,噬菌体具有杀菌作用,在治疗过程中数量会增加,往往只会对正常菌群造成最小程度的破坏,对抗生素敏感菌和耐药菌同样有效,通常很容易被发现,似乎能够破坏细菌生物膜,并且固有毒性较低。除了这些优点外,我们还考虑了噬菌体疗法在安全性、经济性或便利性方面的一些因素,但这些因素对噬菌体对抗细菌的潜力来说可能并非至关重要。例如,在兽医应用中动物之间的自主噬菌体转移可以通过减少重复应用噬菌体的需求而提供便利或经济优势,但对治疗成功不一定至关重要。我们还考虑了将噬菌体用作抗菌剂可能存在的缺点。然而,这些“缺点”往往相对较小。

相似文献

1
Pros and cons of phage therapy.噬菌体疗法的利弊。
Bacteriophage. 2011 Mar;1(2):111-114. doi: 10.4161/bact.1.2.14590.
2
Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.噬菌体衍生抗菌药物:利用噬菌体的简单性、可塑性和多样性。
Viruses. 2019 Mar 18;11(3):268. doi: 10.3390/v11030268.
3
The use of phages for the removal of infectious biofilms.噬菌体用于去除感染性生物膜。
Curr Pharm Biotechnol. 2008 Aug;9(4):261-6. doi: 10.2174/138920108785161604.
4
Bacteriophages and their enzymes in biofilm control.噬菌体及其酶在生物膜控制中的作用
Curr Pharm Des. 2015;21(1):85-99. doi: 10.2174/1381612820666140905112311.
5
Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?噬菌体 - 抗生素联合治疗:抗生素对噬菌体治疗药效学的拮抗作用?
Antibiotics (Basel). 2019 Oct 11;8(4):182. doi: 10.3390/antibiotics8040182.
6
Phage therapy of pulmonary infections.肺部感染的噬菌体疗法。
Bacteriophage. 2015 Apr 18;5(1):e1020260. doi: 10.1080/21597081.2015.1020260. eCollection 2015 Jan-Mar.
7
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.工程噬菌体疗法:原理、挑战与未来。
BioDrugs. 2021 May;35(3):255-280. doi: 10.1007/s40259-021-00480-z. Epub 2021 Apr 21.
8
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.噬菌体疗法:多重耐药时代抗生素的替代方案。
World J Gastrointest Pharmacol Ther. 2017 Aug 6;8(3):162-173. doi: 10.4292/wjgpt.v8.i3.162.
9
Phage therapy pharmacology.噬菌体治疗药理学。
Curr Pharm Biotechnol. 2010 Jan;11(1):28-47. doi: 10.2174/138920110790725410.
10
Phage therapy pharmacology: calculating phage dosing.噬菌体治疗药理学:计算噬菌体剂量
Adv Appl Microbiol. 2011;77:1-40. doi: 10.1016/B978-0-12-387044-5.00001-7.

引用本文的文献

1
Alternatives to antibiotics for sustainable livestock production in the context of the One Health approach: tackling a common foe.在“同一健康”方法背景下实现可持续畜牧生产的抗生素替代方案:应对共同敌人
Front Vet Sci. 2025 Aug 13;12:1605215. doi: 10.3389/fvets.2025.1605215. eCollection 2025.
2
Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways.噬菌体疗法:发现、发展及美国食品药品监督管理局批准途径
Pharmaceuticals (Basel). 2025 Jul 26;18(8):1115. doi: 10.3390/ph18081115.
3
Design of respirable sprayed microparticles of encapsulated bacteriophages.包封噬菌体的可吸入喷雾微粒的设计
Front Drug Deliv. 2023 Jun 14;3:1209534. doi: 10.3389/fddev.2023.1209534. eCollection 2023.
4
Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections.噬菌体疗法治疗胃肠道相关感染所面临挑战的最新见解。
Gut Pathog. 2025 Aug 11;17(1):60. doi: 10.1186/s13099-025-00735-y.
5
The Ability of Bacteriophages to Reduce Biofilms Produced by Isolated from Corneal Infections.噬菌体减少从角膜感染中分离出的细菌所产生生物膜的能力。
Antibiotics (Basel). 2025 Jun 20;14(7):629. doi: 10.3390/antibiotics14070629.
6
Novel MRSA-targeting phage MetB16: Genomic features, structural insights, and therapeutic applications.新型靶向耐甲氧西林金黄色葡萄球菌的噬菌体MetB16:基因组特征、结构解析及治疗应用
Turk J Biol. 2025 Feb 14;49(3):292-308. doi: 10.55730/1300-0152.2746. eCollection 2025.
7
Fighting biofilm: bacteriophages eliminate biofilm formed by multidrug-resistant Enterobacter hormaechei on urological catheters.对抗生物膜:噬菌体可消除多重耐药性霍氏肠杆菌在导尿管上形成的生物膜。
Med Microbiol Immunol. 2025 Jul 3;214(1):33. doi: 10.1007/s00430-025-00844-0.
8
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States.当前美国广泛采用噬菌体疗法面临的临床实验室挑战。
Antibiotics (Basel). 2025 May 29;14(6):553. doi: 10.3390/antibiotics14060553.
9
Protecting bacteriophages under UV irradiation with brilliant blue FCF for targeted bacterial control.用亮蓝FCF在紫外线照射下保护噬菌体以实现靶向细菌控制。
Biofilm. 2025 May 9;9:100286. doi: 10.1016/j.bioflm.2025.100286. eCollection 2025 Jun.
10
Bacteriophages as Targeted Therapeutic Vehicles: Challenges and Opportunities.作为靶向治疗载体的噬菌体:挑战与机遇
Bioengineering (Basel). 2025 Apr 29;12(5):469. doi: 10.3390/bioengineering12050469.

本文引用的文献

1
Bacteriophages as potential new therapeutics to replace or supplement antibiotics.噬菌体作为潜在的新型治疗药物,可以替代或补充抗生素。
Trends Biotechnol. 2010 Dec;28(12):591-5. doi: 10.1016/j.tibtech.2010.08.001. Epub 2010 Aug 31.
2
Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections.多价噬菌体 P-27/HP 对控制人感染相关耐多药金黄色葡萄球菌的疗效。
Curr Microbiol. 2011 Jan;62(1):255-60. doi: 10.1007/s00284-010-9699-x. Epub 2010 Jul 7.
3
Effect of antibiotics in the environment on microbial populations.环境中抗生素对微生物种群的影响。
Appl Microbiol Biotechnol. 2010 Jul;87(3):925-41. doi: 10.1007/s00253-010-2649-5. Epub 2010 May 28.
4
Bacteriophage host range and bacterial resistance.噬菌体宿主范围和细菌耐药性。
Adv Appl Microbiol. 2010;70:217-48. doi: 10.1016/S0065-2164(10)70007-1. Epub 2010 Mar 6.
5
Phage therapy in clinical practice: treatment of human infections.噬菌体疗法在临床实践中的应用:治疗人类感染。
Curr Pharm Biotechnol. 2010 Jan;11(1):69-86. doi: 10.2174/138920110790725401.
6
Phage therapy pharmacology.噬菌体治疗药理学。
Curr Pharm Biotechnol. 2010 Jan;11(1):28-47. doi: 10.2174/138920110790725410.
7
Designing phage therapeutics.设计噬菌体疗法。
Curr Pharm Biotechnol. 2010 Jan;11(1):15-27. doi: 10.2174/138920110790725348.
8
Phage choice, isolation, and preparation for phage therapy.噬菌体的选择、分离和准备用于噬菌体治疗。
Curr Pharm Biotechnol. 2010 Jan;11(1):2-14. doi: 10.2174/138920110790725311.
9
Purification of the Staphylococcus aureus bacteriophages VDX-10 on methacrylate monoliths.在甲基丙烯酸酯整体柱上纯化金黄色葡萄球菌噬菌体 VDX-10。
J Virol Methods. 2010 Jun;166(1-2):60-4. doi: 10.1016/j.jviromet.2010.02.020. Epub 2010 Feb 25.
10
Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy.沙门氏菌噬菌体治疗:噬菌体治疗的新评价。
J Infect Dis. 2010 Jan 1;201(1):52-61. doi: 10.1086/648478.